Toward Flare-Free Images: A Survey

Lens flare is a common image artifact that can significantly degrade image quality and affect the performance of computer vision systems due to a strong light source pointing at the camera. This survey provides a comprehensive overview of the multifaceted domain of lens flare, encompassing its underlying physics, influencing factors, types, and characteristics. It delves into the complex optics of flare formation, arising from factors like internal reflection, scattering, diffraction, and dispersion within the camera lens system. The diverse categories of flare are explored, including scattering, reflective, glare, orb, and starburst types. Key properties such as shape, color, and localization are analyzed. The numerous factors impacting flare appearance are discussed, spanning light source attributes, lens features, camera settings, and scene content. The survey extensively covers the wide range of methods proposed for flare removal, including hardware optimization strategies, classical image processing techniques, and learning-based methods using deep learning. It not only describes pioneering flare datasets created for training and evaluation purposes but also how they were created. Commonly employed performance metrics such as PSNR, SSIM, and LPIPS are explored. Challenges posed by flare's complex and data-dependent characteristics are highlighted. The survey provides insights into best practices, limitations, and promising future directions for flare removal research. Reviewing the state-of-the-art enables an in-depth understanding of the inherent complexities of the flare phenomenon and the capabilities of existing solutions. This can inform and inspire new innovations for handling lens flare artifacts and improving visual quality across various applications

A review of cloud oriented mobile learning platform and frameworks

With the continued growth of mobile devices usage, wireless communications improvement, and cloud computing evolution, many educational institutions around the world, especially universities and colleges, began to provide their students with mobile learning systems based on cloud computing. The widespread, ubiquitous, and flexible natures of mobile devices make mobile learning an attractive alternative in education, particularly when integrating it with cloud computing which is the up-to-date technology that delivers computing hardware and software as services. However, the participatory between mobile learning and cloud computing as a cloud based mobile learning (CBML) becomes one of the important methods in the learning process. Many researches have attempted to combine the unique features of CBML in a form of frameworks. These frameworks have been designed to identify, categorize, or evaluate the major components of the CBML system. This paper is an attempt to identify the important role of cloud computing technology in mobile learning, investigate the main advantages and limitations of CBML systems, and explore the previously designed CBML frameworks

Can the conventional cytology technique be sufficient in a center lacking ROSE?: Retrospective study during the COVID-19 pandemic

While rapid on-site evaluation (ROSE) is considered to be an additional tool to optimize the yield of tissue acquisition during EUS-guided FNA of the gastrointestinal tract (1)(2) it is not readily available at all times while performing these procedures. We reviewed twenty-seven EUS-guided FNA procedures done at our institution in Tripoli central hospital with general working center restrictions due to local COVID-19 prevention protocols. Approximately 92.6 % of tissue adequacy was achieved despite the lack of ROSE which is comparable to ROSE-based tissue acquisition results. This is a small size retrospective chart review study to illustrate the optimal tissue adequacy during EUS-guided FNA of the upper gastrointestinal tract in a suboptimal hospital setting, lack of ROSE and merely utilizing visual inspection of those specimens by the performing physician and its effects on the diagnosis

Key challenges, drivers and solutions for mobility management in 5G networks: a survey

Ensuring a seamless connection during the mobility of various User Equipments (UEs) will be one of the major challenges facing the practical implementation of the Fifth Generation (5G) networks and beyond. Several key determinants will significantly contribute to numerous mobility challenges. One of the most important determinants is the use of millimeter waves (mm-waves) as it is characterized by high path loss. The inclusion of various types of small coverage Base Stations (BSs), such as Picocell, Femtocell and drone-based BSs is another challenge. Other issues include the use of Dual Connectivity (DC), Carrier Aggregation (CA), the massive growth of mobiles connections, network diversity, the emergence of connected drones (as BS or UE), ultra-dense network, inefficient optimization processes, central optimization operations, partial optimization, complex relation in optimization operations, and the use of inefficient handover decision algorithms. The relationship between these processes and diverse wireless technologies can cause growing concerns in relation to handover associated with mobility. The risk becomes critical with high mobility speed scenarios. Therefore, mobility issues and their determinants must be efficiently addressed. This paper aims to provide an overview of mobility management in 5G networks. The work examines key factors that will significantly contribute to the increase of mobility issues. Furthermore, the innovative, advanced, efficient, and smart handover techniques that have been introduced in 5G networks are discussed. The study also highlights the main challenges facing UEs' mobility as well as future research directions on mobility management in 5G networks and beyond

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy

Background: The ability to accurately predict operative duration has the potential to optimise theatre efficiency and utilisation, thus reducing costs and increasing staff and patient satisfaction. With laparoscopic cholecystectomy being one of the most commonly performed procedures worldwide, a tool to predict operative duration could be extremely beneficial to healthcare organisations. Methods: Data collected from the CholeS study on patients undergoing cholecystectomy in UK and Irish hospitals between 04/2014 and 05/2014 were used to study operative duration. A multivariable binary logistic regression model was produced in order to identify significant independent predictors of long (> 90 min) operations. The resulting model was converted to a risk score, which was subsequently validated on second cohort of patients using ROC curves. Results: After exclusions, data were available for 7227 patients in the derivation (CholeS) cohort. The median operative duration was 60 min (interquartile range 45–85), with 17.7% of operations lasting longer than 90 min. Ten factors were found to be significant independent predictors of operative durations > 90 min, including ASA, age, previous surgical admissions, BMI, gallbladder wall thickness and CBD diameter. A risk score was then produced from these factors, and applied to a cohort of 2405 patients from a tertiary centre for external validation. This returned an area under the ROC curve of 0.708 (SE = 0.013, p  90 min increasing more than eightfold from 5.1 to 41.8% in the extremes of the score. Conclusion: The scoring tool produced in this study was found to be significantly predictive of long operative durations on validation in an external cohort. As such, the tool may have the potential to enable organisations to better organise theatre lists and deliver greater efficiencies in care